First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound Mutations
| Autor: | Cheunkarndee, Tia, Guo, Matthew Z., Houseknecht, Stefanie, Feliciano, Josephine L., Hann, Christine L., Lam, Vincent K., Levy, Benjamin P., Murray, Joseph C., Brahmer, Julie R., Forde, Patrick M., Marrone, Kristen A., Scott, Susan C. |
|---|---|
| Zdroj: | In JTO Clinical and Research Reports June 2024 5(6) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|